|Articles|February 10, 2023
SCOPE 2023: Synopsis of Biospecimen Sample Management Presentation
Author(s)Lisa Henderson
Hope Meely, chief clinical officer at Slope, provides a brief summary of her SCOPE presentation revolving around biospecimen collection.
Advertisement
In an interview at the 2023 SCOPE conference with ACT Editor-in-Chief, Lisa Henderson, Hope Meely, chief clinical officer at Slope, explains why biospecimens within the precision and personalized medicine spaces have become so valuable. Meely is coming off her conference presentation, "The Hidden Regulatory Risk from Sample Management — What Should You Be Aware of?”
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed
2
ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment
3
Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations
4
When the Slack Runs Out: AI and the CRO Operating Model
5